Carregant...
Quantitative Interrogation of the Human Kinome Perturbed by Two BRAF Inhibitors
Oncogenic BRAF mutations contribute to the development of a number of cancers, and small-molecule BRAF inhibitors have been approved by the Food and Drug Administration (FDA) for anticancer therapy. In this study, we employed two targeted quantitative proteomics approaches for monitoring separately...
Guardat en:
| Publicat a: | J Proteome Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939617/ https://ncbi.nlm.nih.gov/pubmed/30994353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.9b00134 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|